Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

Published:2004-05-09 Issue:6 Volume:22 Page:701-706
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Smith-Jones Peter M,Solit David B,Akhurst Timothy,Afroze Farzana,Rosen Neal,Larson Steven M

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt968.pdf

Reference30 articles.

1. Ebert, A.D. et al. Expression and function of EGF-related peptides and their receptors in gynecological cancer—from basic science to therapy. J. Recept. Signal Transduct. Res. 20, 1–46 (2000).

2. Yee, K.W. & Keating, A. Advances in targeted therapy for chronic myeloid leukemia. Expert Rev. Anticancer Ther. 3, 295–310 (2003).

3. Slack, J.L. & Rusiniak, M.E. Current issues in the management of acute promyelocytic leukemia. Ann. Hematol. 79, 227–238 (2000).

4. Paterson, S.C., Smith, K.D., Holyoake, T.L. & Jorgensen, H.G. Is there a cloud in the silver lining for imatinib? Br. J. Cancer 88, 983–987 (2003).

5. Mandelli, F., Avvisati, G. & Lo Coco, F. Advances in the understanding and management of acute promyelocytic leukemia. Rev. Clin. Exp. Hematol. 6, 60–71 (2002).

Cited by 274 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular SPECT/CT Profiling of Claudin18.2 Expression In Vivo: Implication for Patients with Gastric Cancer;Molecular Pharmaceutics;2024-06-06

2. ⁶⁸Ga-Labeled Trastuzumab Fragments for ImmunoPET Imaging of Human Epidermal Growth Factor Receptor 2 Expression in Solid Cancers;Cancer Biotherapy and Radiopharmaceuticals;2023-02-01

3. Enabling the formation of native mAb, Fab′ and Fc-conjugates using a bis-disulfide bridging reagent to achieve tunable payload-to-antibody ratios (PARs);Chemical Science;2023

4. Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance;Cells;2022-09-06

5. Therapeutic Response Monitoring with 89Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models;Pharmaceutics;2022-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3